TRAJECTORY OF CARIPRAZINE TREATMENT EFFECTS ACROSS SCHIZOPHRENIA SYMPTOMS: POST HOC ANALYSIS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL

被引：0
|
作者：
Cutler, Andrew J. [1 ]
Durgam, Suresh [2 ]
Lu, Kaifeng [2 ]
Ruth, Adam [3 ]
Laszlovszky, Istvan [4 ]
Nemeth, Gyoergy [4 ]
Meltzer, Herbert Y. [5 ]
机构：
[1] Florida Clin Res Ctr LLC, Bradenton, IL USA
[2] Forest Res Inst, Jersey City, NJ USA
[3] Prescott Med Commun Grp, Chicago, IL USA
[4] Gedeon Richter Plc, Budapest, Hungary
[5] Northwestern Feinberg Sch Med, Chicago, IL USA
来源：
SCHIZOPHRENIA BULLETIN | 2015年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
2086005
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [21] Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial
    Berger, William E.
    Milgrom, Henry
    Skoner, David P.
    Tripp, Kenneth
    Parsey, Merdad V.
    Baumgartner, Rudolf A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (06) : 1217 - 1226
  • [22] RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO- AND ACTIVE-CONTROLLED TRIAL OF TAPENTADOL EXTENDED RELEASE FOR CHRONIC LOW BACK PAIN
    Shapiro, Douglas
    Buynak, Robert
    Okamoto, Akiko
    Van Hove, Ilse
    Steup, Achim
    Lange, Bernd
    Haufel, Thomas
    Etropolski, Mila
    RHEUMATOLOGY, 2010, 49 : I78 - I79
  • [23] Lurasidone in the Treatment of Schizophrenia: A Randomized, Double-Blind, Placebo- and Olanzapine-Controlled Study
    Meltzer, Herbert Y.
    Cucchiaro, Josephine
    Silva, Robert
    Ogasa, Masaaki
    Phillips, Debra
    Xu, Jane
    Kalali, Amir H.
    Schweizer, Edward
    Pikalov, Andrei
    Loebel, Antony
    AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (09): : 957 - 967
  • [24] A RANDOMIZED DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF PREGNENOLONE FOR NEGATIVE SYMPTOMS IN SCHIZOPHRENIA
    Savitz, Adam J.
    Silverstein, Steven
    Rasul, Rehana
    Sharma, Madhulika
    McGovern, Kelly
    English, Judith
    Siegel, Deborah
    Kim, Jason
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S331 - S332
  • [25] Efficacy of frankincense-based herbal product in urinary incontinence: A randomized, double-blind, placebo- and active-controlled clinical trial
    Karbalaiee, Mahbubeh
    Daneshpajooh, Azar
    Khanjani, Narges
    Sohbati, Samira
    Mehrabani, Mehrnaz
    Mehrbani, Mehrzad
    Mehrabani, Mitra
    PHYTOTHERAPY RESEARCH, 2023, 37 (05) : 1754 - 1770
  • [26] Cariprazine as Monotherapy for the Treatment of Predominant Negative Symptoms of Patients with Schizophrenia: A Double-Blind, Active Comparator-Controlled Trial
    Debelle, Marc
    Kahn, Rene
    Laszlovszky, Istvan
    Szalai, Erzsebet
    Nemeth, Gyoergy
    Szatmari, Balazs
    Harsanyi, Judit
    Barabassy, Gota
    Durgam, Suresh
    Fleischhacker, Wolfgang
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S235 - S236
  • [27] Monotherapy treatment with cariprazine for the treatment of predominant negative symptoms of patients with schizophrenia: A double-blind, active comparator-controlled trial
    Nemeth, G.
    Debelle, M.
    Laszlovszky, I.
    Szalai, E.
    Szatmari, B.
    Harsanyi, J.
    Barabassy, A.
    Durgam, S.
    Bitter, I.
    Galderisi, S.
    EUROPEAN PSYCHIATRY, 2016, 33 : S256 - S257
  • [28] Nebulized arformoterol in patients with COPD: A 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial
    Baumgartner, Rudolf A.
    Hanania, Nicola A.
    Calhoun, William J.
    Sahn, Steven A.
    Sciarappa, Kenneth
    Hanrahan, John P.
    CLINICAL THERAPEUTICS, 2007, 29 (02) : 261 - 278
  • [29] Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
    Christiansen, Claus
    Chesnut, Charles H., III
    Adachi, Jonathan D.
    Brown, Jacques P.
    Fernandes, Cesar E.
    Kung, Annie W. C.
    Palacios, Santiago
    Levine, Amy B.
    Chines, Arkadi A.
    Constantine, Ginger D.
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
  • [30] Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled phase 3 study of postmenopausal women with osteoporosis
    Claus Christiansen
    Charles H Chesnut
    Jonathan D Adachi
    Jacques P Brown
    César E Fernandes
    Annie WC Kung
    Santiago Palacios
    Amy B Levine
    Arkadi A Chines
    Ginger D Constantine
    BMC Musculoskeletal Disorders, 11
12345